Methods: Interrectus distance (IRD) was measured at four locations (at the umbilical level, 3 cm above the umbilicus, 6 cm above the umbilicus, and 3 cm below the umbilicus) in 100 healthy nulliparous females and 99 postpartum females, while they remained relaxed and performed a head lift to activate the rectus abdominis muscles. Normal IRD values of the two groups were generated and subsequently compared. 99 postpartum females were subject to ultrasonographic examination of pelvic floor functions, thereby generating the hiatal area of the levator ani muscle and scores of pelvic floor dysfunction. The correlation of these values with diastasis recti was then examined. Results: We established ultrasonographic diagnostic criteria for diastasis recti as follows: IRD > 2 mm at 3 cm below the umbilicus, > 19 mm at the umbilicus, > 13 mm at 3 cm above the umbilicus, and > 7 mm at 6 cm above the umbilicus. The results revealed that IRD was positively correlated with body mass index (BMI) in the control group (r = 0.286) and the subject's age in the patient group (r = 0.23). The incidence of pelvic floor dysfunction was approximately 82.8% among the patients with diastasis recti. Our data indicated that as the abdominal-pelvic pressure increases, IRD and pelvic floor dysfunction also increases. However, once the pressure achieves a certain threshold, pelvic organ prolapse relieves abdominal pressure, reducing the IRD.
OP20.08 Ultrasonic diagnosis and differential diagnosis of enterocele in postpartum female
Objectives: The clinically diagnosed vaginal posterior wall prolapse is often caused by three different structural abnormalities, namely, rectocele, perineal hyperactivity, and enterocele. The objective of this study is to investigate the ultrasonic diagnosis and differential diagnosis of the enterocele in postpartum female. Methods: More than 900 cases of female received a routine pelvic floor ultrasonic examination 42-60 days after childbirth. The volume data was obtained when each examinee was under a rest condition and on maximum Valsalva, the data was saved before it was analysed offline. Results: Among 900 cases of postpartum female, there were 280 cases of clinically-found vaginal posterior wall prolapse, in which there were 8 cases of enterocele, 74 cases of rectocele, 95 cases of perineal hyperactivity and 103 cases were found by ultrasound to have no abnormality. Two-dimensional ultrasound of enterocele is characterised by irregular echoes or ground-glass echoes. When the hernation is the small intestine, peristalsis and gas-like scintillation echoes are visible and sometimes the fluid inside the peritoneal cavity enters the vagina. It is easy to distinguish the enterocele from the rectocele when rectal ampulla is identified. The rectal ampulla is generally wedge-shape hyperechogenic with distal shadowing when filled with stool and air. Peristalsis of the rectal ampulla is not obvious as well as small intestine. Three-dimensional ultrasound axial plane shows the irregular vaginal mass which is not connected with the anal canal. The anal canal wall is continuous and complete. Conclusions: Some studies have shown that transvaginal ultrasonography and defecography have a better comparability during diagnosis of enterocele, so the study of application of transvaginal ultrasound in the diagnosis of enterocele will be conducive to clinical treatment decision-making, and will improve the efficiency of treatment. This study shows that perineal two-dimensional ultrasound and three-dimensional ultrasound are effective imaging methods for the diagnosis of enterocele. Objectives: Our aim was to evaluate total cell-free DNA (cfDNA) as a predictor of pre-eclampsia (PE). Methods: A systematic review was conducted by searching Pubmed and Medline using the keywords: total cell free DNA, cell free fetal DNA, maternal cell free DNA, pre-eclampsia, and adverse pregnancy outcome. Literature reporting levels of total cfDNA in development of PE were included. Studies that only reported fetal cell-free DNA (cffDNA) but no cfDNA concentrations were not included in this review. Results: 206 articles were collected from Pubmed and Medline through literature review. 108 were selected after 98 duplicates removed. Two investigators independently reviewed the abstracts. Based on the selection criteria, 100 articles were excluded. Finally, 8 studies were included in this review. Seven reported the values of cfDNA in PE patients, regardless of early or late onset PE, six of which demonstrated a significant increase of maternal cfDNA levels in patients with later developed PE. Seven studies evaluated cfDNA levels in the first trimester, six of which showed a significant increase of cfDNA concentrations in women with later developed PE compared to controls. Five studies investigated cfDNA levels in the second trimester, all presenting increased total cfDNA levels in the PE group compared to normal controls. Conclusions: Based on this systematic review, cfDNA might be a more reliable and promising biochemical marker for prediction of PE, compared with cffDNA. Large prospective studies with homogeneous populations and standardised methodology are needed to further confirm the predictive potential of total cfDNA.
OP21: PLACENTAL DISORDERS
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Placental structure and vascularisation in IVF/ICSIpregnancies compared to naturally conceived pregnancies V. Schiffer, C. Vrouwenraets, A. van Montfoort, N. Mohseni, M. Spaanderman, S. Al Nasiry
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Objectives: Although pregnancy rates of artificial reproductive techniques (ART) pregnancies have been optimised, these pregnancies have a higher risk of pregnancy complications due to impaired placentation during early pregnancy and thereby affecting placental vascularisation, structure and later on fetal growth. The aim of this study is to investigate if there are placental ultrasonographic differences between ART-and naturally conceived pregnancies. Methods: A cross-sectional pilot study included 35 ART-and 30 naturally conceived (NC) pregnancies at the Maastricht University Medical Centre, between October 2017 and March 2018. Inclusion criteria were singleton pregnancies (NC, IVF/ICSI), maternal age ≥
